Jeju National University Hospital
23
7
7
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 23 trials
100.0%
+13.5% vs industry average
35%
8 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Long-term Prospective Study of Korean CADASIL Patients
Role: lead
Long-term Beta-blocker Therapy After Acute Myocardial Infarction
Role: collaborator
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Role: collaborator
Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)
Role: collaborator
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Role: collaborator
Severe Sepsis and Septic Shock Registry
Role: collaborator
Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease
Role: collaborator
CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study
Role: collaborator
Paraclinoid ANeurysm Prospectively Driven ObseRvational Analysis (PANDORA) Study
Role: collaborator
Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients
Role: collaborator
KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease
Role: collaborator
Norepinephrine and Phenylephrine for Maternal Cardiac Output During Spinal Anesthesia for Elective Cesarean Delivery
Role: lead
Open Versus Laparoscopic Left-sided Hepatectomy Trial
Role: collaborator
Clinical Course of Korean Crohn's Disease Cohort
Role: collaborator
DXR Stent for Vascular Healing and Thrombus Formation: OCT Study
Role: collaborator
A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension
Role: collaborator
A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension
Role: collaborator
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
Role: collaborator
Fimasartan/Amlodipine Combination Phase III
Role: collaborator
Effects of Jeju Red Horsehead Fish-based, High Protein Diet on Satiety and Incretin Hormones in Diabetes Patients
Role: lead